Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

MELCAYA Novel health care strategies for melanoma in children, adolescents and young adults

Coordinator
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer, Spain
Runs
1 December 2022 to 30 November 2026
Status
Running
EU funding
€8.0m
Total cost
€8.0m
Partners
27 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101096667

What the project is doing

In the project's own words, from its summary on CORDIS.

In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized approaches lead to a very low diagnostic accuracy. The MELCAYA project aims to understand risk factors and determinants of melanoma to improve the prevention, diagnosis and prognosis of melanomas in CAYAs through a strong international consortium with experts from 10 countries in different disciplines (e.g. oncology, paediatrics, ethics, policy making), and sectors (e.g. academic centers, SMEs, hospitals, patient associations).

MELCAYA will work on different approaches. 1) By integrating existing reference European cohorts and registries, studies of genetic and environmental risk factors and progression of melanoma in CAYA will be performed through different omic methods, and a novel taxonomy of CAYA melanoma will be generated. 2) MELCAYA will also develop image-based robust and trustworthy machine learning tools and a pan-European second-opinion platform for better diagnosis specifically designed for CAYA. 3) Moreover, the validation of minimally and non-invasive disruptive tools based on artificial intelligence and volatilomics detection from exhaled breath and skin will lead to earlier detection and more accurate prognosis of melanoma in CAYA. 4) Finally, through the evidence gathered, MELCAYA will design and implement public health strategies and will actively involve patients and the general population.

The results of MELCAYA will maximize its impact by making its data and results accessible and re-usable through integration into UNCAN.eu. This action is part of the Cancer Mission cluster of projects on ‘‘Understanding"".""

Topics

Who is involved

OrganisationCityCountryRole
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainCoordinator
Synyo GmbHWienAustriaParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyAssociatedpartner
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Iuf - Leibniz-Institut Fur Umweltmedizinische Forschung GmbHDusseldorfGermanyParticipant
Athena Tech SLBarcelonaSpainParticipant
Fundacio Institut D'investigacio Biomedica De BellvitgeL'Hospitalet De LlobregatSpainThird party
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Institut Catala D'oncologiaHospitalet de LlobregatSpainParticipant
Institut CurieParisFranceAssociatedpartner
Universite D'aix MarseilleMarseilleFranceParticipant
Technion - Israel Institute of TechnologyHaifaIsraelParticipant
Agenzia Nazionale per I Servizi Sanitari RegionaliRomaItalyParticipant
Azienda Ospedaliera Universitaria Meyer IrccsFirenzeItalyThird party
Fondazione Irccs Istituto Nazionale Dei TumoriMilanItalyParticipant
Fondazione Policlinico Universitario Agostino Gemelli IrccsRomaItalyThird party
Universita Cattolica Del Sacro CuoreMilanoItalyParticipant
Universita Degli Studi Di FirenzeFlorenceItalyParticipant
Universita Degli Studi Di PerugiaPerugiaItalyParticipant
Nevus Netwerk NederlandLeusdenNetherlandsAssociatedpartner
Prinses Maxima Centrum Voor Kinderoncologie BVUtrechtNetherlandsParticipant
Gdanski Uniwersytet MedycznyGdanskPolandAssociatedpartner
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut BadawczyWarszawaPolandParticipant
Asociatia Melanom RomaniaBucurestiRomaniaParticipant
Region StockholmStockholmSwedenParticipant
Istanbul UniversitesiIstanbulTürkiyeAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI